Fibromialgia para neurólogos. Controversias sobre una consulta frecuente

Lawrence, 2008, National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II, Arthritis Rheum, 58, 26, 10.1002/art.23176 Branco, 2010, Prevalence of fibromyalgia: a survey in five European countries, Semin Arthritis Rheum, 39, 448, 10.1016/j.semarthrit.2008.12.003 Wolfe, 1995, The prevalence and characteristics of fibromyalgia in the general population, Arthritis Rheum, 38, 19, 10.1002/art.1780380104 Miedema, 1998, National database of patients visiting rheumatologists in The Netherlands: the standard diagnosis registers of rheumatic diseases. A report and preliminary analysis, Br J Rheumatol, 37, 555, 10.1093/rheumatology/37.5.555 Gowers, 1904, Lumbago: its lessons and analogues, Br Med J, 1, 117, 10.1136/bmj.1.2246.117 Graham, 1953, The fibrosits syndrome, Bull Rheum Dis, 3, 33 Smythe, 1977, Two contributions to understanding of the fibrositis syndrome, Bull Rheum Dis, 28, 928 Wolfe, 1990, The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee, Arthritis Rheum, 33, 160, 10.1002/art.1780330203 [consultado 12/2010]. http://apps.who.int/classifications/apps/icd/icd10online/World Health Organization online resource: ICD version 2007. Wolfe, 2009, Fibromyalgia Wars, J Rheumatol, 36, 671, 10.3899/jrheum.081180 Rivera Redondo, 2004, Controversias en el diagnóstico de fibromialgia, Rev Esp Reumatol, 31, 501 Belenguer, 2009, Clasificacion de la Fibromialgia. Revisión de la literatura, Reum Clin, 5, 55, 10.1016/j.reuma.2008.07.001 Smith, 2010, Fibromyalgia Syndrome: A Discussion of the Syndrome and Pharmacotherapy, Am J Therap, 17, 418, 10.1097/MJT.0b013e3181df8e1b Wolfe, 2011, Mortality in fibromyalgia: An 8,186 patient study over 35 years, Arthritis Care Res (Hoboken), 63, 94, 10.1002/acr.20301 Kuchinad, 2007, Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain, J Neurosci, 27, 4004, 10.1523/JNEUROSCI.0098-07.2007 Gracely, 2002, Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia, Arthritis Rheum, 46, 1333, 10.1002/art.10225 Williams, 2006, Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia, Arthritis Res Ther, 8, 224, 10.1186/ar2094 Katz, 2007, The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation, Med Hypotheses, 69, 517, 10.1016/j.mehy.2005.10.037 Ozgocmen, 2006, Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns, Rheumatol Int, 26, 598, 10.1007/s00296-005-0079-y Buskila, 1997, Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury, Arthritis Rheum, 40, 446, 10.1002/art.1780400310 Reyero, 2010, High frequency of childhood ADHD history in women with fibromyalgia, Eur Psychiatry, 26, 482, 10.1016/j.eurpsy.2010.03.012 Buskila, 2006, Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome, Arthritis Res Ther, 8, 218, 10.1186/ar2005 Cohen, 2002, Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits, Arthritis Rheum, 46, 845, 10.1002/art.10103 Buskila, 2004, An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits, Mol Psychiatry, 9, 730, 10.1038/sj.mp.4001506 Gürsoy, 2003, Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome, Rheumatol Int, 23, 104, 10.1007/s00296-002-0260-5 Pongratz, 2000, Fibromyalgia-symptom or diagnosis: a definition of the position, Scand J Rheumatol, 113, 3 Russel, 1994, Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome, Arthritis Rheum, 37, 1593, 10.1002/art.1780371106 Yunus, 2007, Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain, Best Pract Res Clin Rheumatol, 21, 481, 10.1016/j.berh.2007.03.006 Bazzichi, 2007, Cytokine patterns in fibromyalgia and their correlation with clinical manifestations, Clin Exp Rheumatol, 25, 225 Wallace, 2001, Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study, Baillieres Clin Rheumatol, 40, 743 Sarchielli, 2007, Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome, J Pain, 8, 737, 10.1016/j.jpain.2007.05.002 Bigatti, 2008, Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression, Arthritis Rheum, 59, 961, 10.1002/art.23828 Carson, 2000, Do medically unexplaines symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics, JNNP, 68, 207 Wolfe, 2010, The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity, Arthritis Care Res, 62, 600, 10.1002/acr.20140 Hahn, 2007, Precision of health-related quality of-life data compared with other clinical measures, Mayo Clin Proc, 82, 1244, 10.4065/82.10.1244 Williams, 2009, Advances in the Assessment of Fibromyalgia, Rheum Dis Clin North Am, 35, 339, 10.1016/j.rdc.2009.05.007 Buskila, 2009, Developments in the scientific and clinical understanding of fibromyalgia, Arthritis Res Ther, 11, 242, 10.1186/ar2720 Bernard, 2000, Quality of life issues for fibromyalgia patients, Arthritis Care Res, 13, 42, 10.1002/1529-0131(200002)13:1<42::AID-ART7>3.0.CO;2-R Schweinhardt, 2008, Fibromyalgia: a disorder of the brain, Neuroscientist, 14, 415, 10.1177/1073858407312521 Podolecki, 2009, Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns, Pol Arch Med Wewn, 119, 157 Bennett, 2007, An internet survey of 2,596 people with fibromyalgia, BMC Musculoskelet Disord, 8, 27, 10.1186/1471-2474-8-27 Carmona, 2001, The burden of musculoskeletal diseases in the general population of Spain: results from a national survey, Ann Rheum Dis, 60, 1040, 10.1136/ard.60.11.1040 Ehrlich, 2003, Fibromyalgia a virtual disease, Clin Rheumatol, 22, 8, 10.1007/s10067-002-0697-7 Macfarlane, 1996, The natural history of chronic pain in the community: a better prognosis than in the clinic, J Rheumatol, 23, 1617 Hadler, 2003, Fybromialgia and the medicalization of misery, The Journal of Rheumatology, 30, 1668 Maiden, 2003, Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations, Rheumatology, 42, 108, 10.1093/rheumatology/keg043 Benjamin, 2000, The association between chronic widespread pain and mental disorder, Arthritis Rheum, 43, 561, 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O Hadler, 1996, If you have to prove you are ill, you can’t get well. The object lesson of fibromyalgia, Spine, 21, 2397, 10.1097/00007632-199610150-00021 Barkin, 2008, Pregabalin: a critical review, Pain Med Network, 24, 8 Häuser, 2009, Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials, Pain, 145, 69, 10.1016/j.pain.2009.05.014 Barkin, 2007, Duloxetine. A pharmacological overview, Pain Med Network, 22, 8 Arnold, 2009, Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials, Prim Care Companion J Clin Psychiatry, 11, 237, 10.4088/PCC.08m00680 Hansten, 2010 Mease, 2009, The efficacy and safety of milnacipran for treatment of fibromyalgia, a randomized, double-blind, placebo-controlled trial, J Rheumatol, 36, 398, 10.3899/jrheum.080734 Clauw, 2008, Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial, Clin Ther, 30, 1988, 10.1016/j.clinthera.2008.11.009 Goldenberg, 2010, Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study, Pain Med, 11, 180, 10.1111/j.1526-4637.2009.00755.x Häuser, 2010, Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome, J Pain, 11, 505, 10.1016/j.jpain.2010.01.002 Vergne-Salle, 2011, A randomized, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia, Eur J Pain, 15, 509, 10.1016/j.ejpain.2010.09.013 Arnold, 2010, Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study, Clin Ther, 32, 1618, 10.1016/j.clinthera.2010.08.003 Bernardy, 2010, Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials, J Rheumatol, 37, 1991, 10.3899/jrheum.100104 Rooks, 2007, Group exercise, education, and combination self-management in women with fibromyalgia: a randomized trial, Arch Intern Med, 167, 2192, 10.1001/archinte.167.20.2192 Häuser, 2010, Efficacy of land meta-analysis of randomized controlled trials, Arthritis Res Ther, 12, R79, 10.1186/ar3002 Baranowsky, 2009, Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia, Rheumatol Int, 30, 1, 10.1007/s00296-009-0977-5 Wang, 2010, A randomized trial of tai-chi for fibromyalgia, N Engl J Med, 363, 743, 10.1056/NEJMoa0912611 Yunus, 2007, Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes, Semin Arthritis Rheum, 36, 339, 10.1016/j.semarthrit.2006.12.009 Valença, 2009, Neuroendocrine dysfunction in fibromyalgia and migraine, Curr Pain Headache Rep, 13, 358, 10.1007/s11916-009-0058-1 May, 2009, Morphing voxels: the hype around structural imaging of headache patients, Brain, 132, 1419, 10.1093/brain/awp116 May, 2008, Chronic pain may change the structure of the brain, Pain, 137, 7, 10.1016/j.pain.2008.02.034 Schmidt-Wilcke, 2005, Gray matter decrease in patients with chronic tension-type headache, Neurology, 65, 1483, 10.1212/01.wnl.0000183067.94400.80 Apkarian, 2004, Chronic back pain is associated with decreased prefrontal and thalamic gray matter density, J Neurosci, 24, 10410, 10.1523/JNEUROSCI.2541-04.2004 Hsu, 2009, No consistent difference in Gray Matter Volume between individuals with fibromyalgia an age-matched healthy subjects when controlling for affective disorder, Pain, 143, 262, 10.1016/j.pain.2009.03.017 Goldenberg, 1995, Fibromyalgia: why such controversy, Ann Rheum Dis, 54, 3, 10.1136/ard.54.1.3